期刊文献+

利妥昔单抗治疗婴儿难治性自身免疫性溶血性贫血伴假性血小板减少一例报告附文献复习 被引量:2

原文传递
导出
摘要 自身免疫性溶血性贫血(AIHA)系体内B淋巴细胞免疫调节紊乱,产生自身抗体和(或)补体,并结合于红细胞膜上,致红细胞破坏加速而引起的一组溶血性贫血。婴儿难治性AIHA症状重,病程迁延,病死率高,治疗目标是迅速控制溶血。利妥昔单抗治疗成人原发免疫性血小板减少症(ITP)、AIHA及Evans综合征安全有效。
出处 《中华血液学杂志》 CAS CSCD 北大核心 2012年第11期957-959,共3页 Chinese Journal of Hematology
  • 相关文献

参考文献19

  • 1Motta M, Cavazza A, Migliori C,et al. Autoimmune haemolytic anaemia in a newborn infant. Arch Dis Child Fetal Neonatal Ed, 2003,88 : 341-342.
  • 2Ng PC, Lee KK, Lo AF,et al. Anti-B cell targeted immunotherapy for treatment of refractory autoimmune haemolytic anaemia in a young infant. Arch Dis Child, 2003,88:337-339.
  • 3Pefialver FJ, Alvarez-Larrdn A, Diez-Martin JL,et al. Rituximab is an effective arid safe therapeutic alternative in adults with refrac- tory and severe autoimmune hemolytic anemia. Ann Hematol, 2010,89 : 1073-1080.
  • 4Vaglio S, Arista MC, Perrone MP, et al. Autoimmune hemolytic anemia in childhood: serologic features in 100 cases. Transfusion, 2007,47:50-54.
  • 5Svahn J, Fioredda F, Calvillo M, et al. Rituximab-based immuno- suppression for autoimmune haemolytic anaemia in infants. Br J Haematol, 2009,145:96-100.
  • 6Stasi R. Rituximab in autoimmune hematologic diseases: not just a matter of B cells. Semin Hematol, 2010,47:170-179.
  • 7Taylor RP, Lindorfer MA. Drug insight the mechanism of action of rituximab in autoimnmne disease the immune complex decoy hy-pothesis. Nat Clin Pract Rheumatol, 2007,3:86-95.
  • 8Bader-Meunier B, Aladjidi N, Bellmann F,et al. Rituximab thera- py for childhood Evans syndrome. Haematologica, 2007,92:1691- 1694.
  • 9Zecca M, Nobili B, Ramenghi U, et al. Rituximab for "the treat- ment of refractory autoimmune hemolytic anemia in children. Blood, 2003,101:3857-3861.
  • 10Dierickx D, Verhoef G, Van Hoof A, et al. Rituximab in auto- immune haemolytie anaemia and immune thrombocytopenic purpu- ra: a Belgian retrospective multicentrie study. J Intern Med, 2009, 266:484-491.

同被引文献16

  • 1赵湜,王红祥,李菁媛,毛红,邹萍.调节性T细胞在慢性特发性血小板减少性紫癜中的作用[J].中华血液学杂志,2006,27(3):203-205. 被引量:17
  • 2Sakaguchi S, Yamaguchi T, Nomura T, et al. Regulatory T ceils and immune tolerance [ J ]. Ce11,2008,133 (5) :775-787.
  • 3Liu MF,Wang CR,Fung LL,et al. Decreased CD4+ CD+T cells in peripheral blood of patients with systemic lupus erythematosus [J]. Scand J Immunol,2004,59(2) :198-202.
  • 4Crispin JC, Martines A, Alcocer-Varela J. Quantification of regula- tory T-cells in patients with systemic lupus erythematosus [ J ]. J Autoimmun ,2003,21 (3) :273-276.
  • 5Chen J, Ellison FM, Eckhaus MA, et al. Minor antigen H60-medi- ated aplastic anemia is ameliorated by immunosuppression and the infusion of regulatory T-cells [ J ]. J Immunol, 2007,178 ( 7 ) : 4159-4168.
  • 6Yu J ,Heck S,Patel : ,el al. Defective circulating CD25 regulate-ry T cells in patients with chronic immune thrombocytopenic pur- pura[J]. Blood,2008,112(4) :1325-1328.
  • 7Mqadmi A, Zheng XY, Yazdanbakhah K. CD4+ CD5+ regulatory T cells control induction of autoimmune hemolytic anemia [ J ]. Blood,2005,105 (9) :3746-3748.
  • 8Brunkow ME, Jeffery EW, Hjerrild KA, et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lym- phoproliferative disorder of the scurfy mouse [ J ]. Nat. Genet, 2001,27( 1 ) :68-73.
  • 9Hod S, Nomura T, Sakaguchi S. Control of regulatory T cell devel- opment by the transcription factor Foxp3 [ J ]. Science, 2003,299 ( 1 ) : 1057-1061.
  • 10Marson A, Kretschmer K, Frampton GM, et al. Foxp3 occupancy and regulation of key target genes during T-cell stimulation [ J ]. Nature ,2007,445 (7130) :931-935.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部